BSE Live
Oct 20, 16:01Prev. Close
445.30
Open Price
445.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 20, 15:54Prev. Close
446.50
Open Price
449.40
Bid Price (Qty.)
434.35 (150)
Offer Price (Qty.)
0.00 (0)
Cash Flow of Panacea Biotec (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | -171.22 | 46.23 | -66.14 | -51.88 | -18.93 | |
Net CashFlow From Operating Activities | -30.47 | 104.88 | 118.02 | 130.67 | 90.69 | |
Net Cash Used In Investing Activities | -34.76 | -5.35 | 55.29 | -25.83 | 16.44 | |
Net Cash Used From Financing Activities | 90.74 | -101.14 | -164.35 | -106.96 | -117.38 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 25.51 | -1.61 | 8.97 | -2.13 | -10.25 | |
Cash And Cash Equivalents Begin of Year | 14.71 | 16.08 | 7.47 | 9.59 | 19.99 | |
Cash And Cash Equivalents End Of Year | 40.22 | 14.47 | 16.44 | 7.47 | 9.74 |
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
24.04.2025
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
28.11.2024
Panacea Biotec Consolidated September 2024 Net Sales at Rs 147.35 crore, up 3.03% Y-o-Y